EverGlade Consulting Welcomes New Managing Director, Joe Larsen
/PRNewswire/ -- EverGlade Consulting is pleased to announce the appointment of Dr. Joe Larsen as Managing Director, effective April 2024. Dr. Larsen brings...
Source: prnewswire.com
Page 46 - Clinical Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Clinical Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Clinical Development Today - Breaking & Trending Today
SYNAGIS (Palivizumab) for Respiratory Syncytial Virus (RSV)
Dublin, April 30, 2024 (GLOBE NEWSWIRE) -- The
Source: globenewswire.com
Pfizer's ABRYSVO (RSVpreF) for Respiratory Syncytial Virus
Dublin, April 30, 2024 (GLOBE NEWSWIRE) -- The
Source: globenewswire.com
Opthea : Quarterly Activity Report - Form 6-K
Quarterly Activity Report Q3 FY24 Highlights • Completion of enrolment in first trial of sozinibercept's Phase 3 pivotal program...
Source: marketscreener.com
SYNAGIS (Palivizumab) for Respiratory Syncytial Virus (RSV) in 7MM: Market Size, Forecasts, and Emerging Insights 2019-2023 & 2023-2032
Dublin, April 30, 2024 (GLOBE NEWSWIRE) -- The "SYNAGIS Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights about SYNAGIS for Respiratory syncytial virus (RSV) in the seven major markets. A detailed picture of the SYNAGIS for RSV in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019-2032 is provided in this report
Source: yahoo.com